World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 22 March 2021
Main ID:  NCT04800055
Date of registration: 12/03/2021
Prospective Registration: No
Primary sponsor: PATH
Public title: Attractive Targeted Sugar Bait Phase III Trial in Zambia
Scientific title: Attractive Targeted Sugar Bait Phase III Trial in Zambia
Date of first enrolment: December 1, 2020
Target sample size: 3480
Recruitment status: Recruiting
URL:  https://clinicaltrials.gov/show/NCT04800055
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: None (Open Label).  
Phase:  N/A
Countries of recruitment
Zambia
Contacts
Name:     Kafula Silumbe, MPH
Address: 
Telephone: +260978774230
Email: ksilumbe@path.org
Affiliation: 
Name:     John M Miller, PhD
Address: 
Telephone: +260977510414
Email: jmiller@path.org
Affiliation: 
Key inclusion & exclusion criteria

Inclusion Criteria:

- Household resident

- =12 months and <15 years of age at the time of enrollment

- If age 12 months - 6 years of age, parent or guardian provides consent for child's
participant

- If age 7-14 years, parent or guardian provides consent for child's participant and
child provides assent for participation

Exclusion Criteria:

- Residence within the buffer zone

- Age <12 months or =15 years of age at the time of cohort enrollment

- Household contained a participant in the first cohort (for participation in the second
cohort)

- Pregnant at the time of cohort enrollment. Pregnant adolescents are excluded because
they are eligible for protection from infection through pregnancy standard of care -
intermittent preventative therapy during pregnancy (IPTp), and to avoid undue
discomfort with repeated blood sampling.

- Pregnancy at any time during the cohort study. Pregnancy will be identified in
adolescents at enrollment and follow-up visits through a single question regarding
pregnancy status during each cohort visit. When an adolescent indicates that she is
pregnant or is unsure of her pregnancy status, she will no longer be followed for
ongoing blood testing for the reasons noted above and will be censored in the
analysis.

- Does not provide consent/assent required according to age to participate in the study



Age minimum: 12 Months
Age maximum: 15 Years
Gender: All
Health Condition(s) or Problem(s) studied
Malaria
Malaria,Falciparum
Vector-Borne Transmission of Infection
Intervention(s)
Other: Attractive Targeted Sugar Bait
Primary Outcome(s)
Clinical malaria case incidence [Time Frame: Seasonal (6 months)]
Secondary Outcome(s)
Incidence rate of passively reported clinical malaria [Time Frame: Seasonal (6 months)]
Prevalence, detected by PCR [Time Frame: 6 weeks]
Prevalence, detected by RDT [Time Frame: 6 weeks]
Time to first infection [Time Frame: Seasonal (6 months)]
Secondary ID(s)
1460046
1460046-5
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Macha Research Trust, Zambia
Ministry of Health, Zambia
Tulane University
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history